James J. CAMPBELL,Rajinder SINGH,Samuel HWANG,Xueson WU,Jeffrey K. HARRISON
申请号：
US16824585
公开号：
US20200297708A1
申请日:
2020.03.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure is drawn to the combination therapy of a Chemokine Receptor 2 (CCR2) antagonist and a PD-1 and/or PD-L1 inhibitor in the treatment of a central nervous system cancer.
